|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 9/00 | |||
| A61P 27/02 | |||
| A61K 9/22 | |||
| A61K 47/30 |
| (11) | Number of the document | 1773350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05772211.8 |
| Date of filing the European patent application | 2005-07-11 | |
| (97) | Date of publication of the European application | 2007-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/024897 |
| Date | 2005-07-11 |
| (87) | Number | WO 2006/017347 |
| Date | 2006-02-16 |
| (30) | Number | Date | Country code |
| 587092 P | 2004-07-12 | US |
| (72) |
WHITCUP, Scott, M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | OPTHALMIC COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS |
| OPTHALMIC COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS |